GL1X · GenesisL1 explorer

Research workbench

The crystal structure of SARS-cov-2 main protease in complex with GC376

Analyse The crystal structure of SARS-cov-2 main protease in complex with GC376 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7CBT
Type
protein
Length
596 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
K36
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinase (EC 3.4.22.69)protein29826% helix, 29% strandP0DTD1

Ligands and binding sites

  • K36 · (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111880.760.7890empty
23100.560.7643empty
32060.520.7729K36
41800.500.7726K36
51670.460.7528empty

Interfaces

1 interface between chains.

  • A–B · 1052 Ų buried · 22 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7CBT · The crystal structure of SARS-CoV-2 main protease in complex with GC376 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.